Nepafenac ophthalmic Pregnancy and Breastfeeding Warnings
Nepafenac ophthalmic is also known as: Ilevro, Nevanac
Nepafenac ophthalmic Pregnancy Warnings
Nepafenac ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have failed to reveal signs of teratogenicity. There have been reports of dystocia, increased post-implantation loss, reduced fetal weights and growth, and reduced fetal survival in rats following dosages of at least 10 mg/kg. There are no controlled data in human pregnancy. Nepafenac ophthalmic is only recommended for use during pregnancy when benefit outweighs risk. Nepafenac ophthalmic should be avoided during late pregnancy due to the possible adverse effects on the fetal cardiovascular system (closure of the ductus arteriosus) reported with nonsteroidal anti-inflammatory agents.
Nepafenac ophthalmic Breastfeeding Warnings
There are no data on the excretion of nepafenac ophthalmic into human milk. The manufacturer recommends that caution be used when administering nepafenac ophthalmic to nursing women.
See Also...
- Nepafenac Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
